A novel role of Shc adaptor proteins in steroid hormone-regulated cancers

Syed Mahfuzul Alam1, Mythilypriya Rajendran, Shouqiang Ouyang

  • 1Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, Nebraska 68198-5870, USA.

Endocrine-Related Cancer
|November 13, 2008
PubMed

Insights

Shc proteins link tyrosine phosphorylation and steroid signaling in cancer. The p66(Shc) protein mediates steroid action through redox signaling, offering a potential biomarker and therapeutic target for cancer prognosis.

Area of Science:

  • Molecular biology
  • Cell signaling
  • Cancer research

Background:

  • Tyrosine phosphorylation is crucial for cell growth and its dysregulation contributes to cancer.
  • Shc (Src homolog and collagen homolog) adaptor proteins are key players in tyrosine phosphorylation signaling pathways.
  • Steroids are implicated in carcinogenesis and cancer progression, with recent evidence suggesting crosstalk with tyrosine phosphorylation signaling.

Purpose of the Study:

  • To explore the role of Shc proteins, specifically p52(Shc) and p66(Shc), in steroid hormone-regulated cancers.
  • To elucidate a novel molecular mechanism involving p66(Shc)-induced redox signaling in mediating steroid action via a non-genomic pathway.

Main Methods:

  • The study discusses the established roles of Shc proteins in signaling pathways.
  • It reviews recent evidence on the crosstalk between tyrosine phosphorylation and steroid hormone action.
  • Focuses on the molecular mechanism of p66(Shc)-mediated steroid action.

Main Results:

  • Shc proteins may act as mediators between tyrosine phosphorylation and steroid signaling in cell proliferation and carcinogenesis.
  • A novel mechanism reveals that p66(Shc)-induced redox signaling mediates steroid action through a non-genomic pathway.
  • p66(Shc) shows potential as a biomarker for cancer prognosis and a therapeutic target.

Conclusions:

  • Shc proteins, particularly p52(Shc) and p66(Shc), play significant roles in steroid hormone-regulated cancers.
  • The p66(Shc) protein mediates steroid action via non-genomic redox signaling, presenting a novel therapeutic avenue.
  • p66(Shc) could serve as a valuable biomarker for predicting cancer outcomes and guiding treatment strategies.

Related Concept Videos

Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...